Benign epithelial ovarian tumours-cancer precursors or markers for ovarian cancer risk?
- PMID: 16633908
- DOI: 10.1007/s10552-005-0370-y
Benign epithelial ovarian tumours-cancer precursors or markers for ovarian cancer risk?
Abstract
The natural history of the development of epithelial ovarian cancer remains obscure and no effective screening test exists. In several human malignancies progression from benign to invasive tumour occurs, but this sequence has not been established for epithelial ovarian cancer. We have reviewed epidemiological, histopathological and molecular studies of benign epithelial ovarian tumours to assess the evidence for and against such a progression in ovarian cancer. These data suggest that a diagnosis of a benign ovarian cyst or tumour is associated with an increased risk of ovarian cancer later in life. Current evidence also suggests that benign serous tumours can progress to low-grade serous cancer and that benign mucinous tumours can progress to mucinous cancer. The more common high-grade serous ovarian cancers are likely to arise de novo.
Similar articles
-
Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses.Mol Cell Endocrinol. 2006 Mar 9;247(1-2):4-21. doi: 10.1016/j.mce.2005.09.014. Epub 2005 Nov 16. Mol Cell Endocrinol. 2006. PMID: 16297528 Review.
-
Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?Gynecol Oncol. 2007 Nov;107(2):223-30. doi: 10.1016/j.ygyno.2007.06.006. Epub 2007 Jul 27. Gynecol Oncol. 2007. PMID: 17662378
-
Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.Histopathology. 2013 Jan;62(1):44-58. doi: 10.1111/his.12046. Histopathology. 2013. PMID: 23240669 Review.
-
Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways.J Pathol. 2005 Sep;207(1):20-6. doi: 10.1002/path.1817. J Pathol. 2005. PMID: 16021676
-
Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach.Gynecol Oncol. 2003 Mar;88(3):309-17. doi: 10.1016/s0090-8258(02)00104-x. Gynecol Oncol. 2003. PMID: 12648580
Cited by
-
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.Endocr Relat Cancer. 2013 Mar 22;20(2):251-62. doi: 10.1530/ERC-12-0395. Print 2013 Apr. Endocr Relat Cancer. 2013. PMID: 23404857 Free PMC article.
-
Overexpression of TROP2 promotes proliferation and invasion of ovarian cancer cells.Exp Ther Med. 2017 Sep;14(3):1947-1952. doi: 10.3892/etm.2017.4788. Epub 2017 Jul 12. Exp Ther Med. 2017. PMID: 28962108 Free PMC article.
-
Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study.Int J Cancer. 2017 Jan 15;140(2):285-291. doi: 10.1002/ijc.30441. Epub 2016 Oct 6. Int J Cancer. 2017. PMID: 27667654 Free PMC article.
-
Screening, epidemiology, molecular biology, and treatment strategies for endometriosis-associated ovarian cancer.Reprod Med Biol. 2009 Sep 26;9(1):17-22. doi: 10.1007/s12522-009-0034-9. eCollection 2010 Mar. Reprod Med Biol. 2009. PMID: 29699327 Free PMC article. Review.
-
Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review.Fertil Res Pract. 2016 Dec 5;2:14. doi: 10.1186/s40738-016-0029-2. eCollection 2016. Fertil Res Pract. 2016. PMID: 28620541 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical